# Synthesis: Confirmed-BBraun MI Demo - virtual.pdf

Generated on: 2026-01-16

## Coverage / Limit Warnings
- [PDF_REDUNDANCY_DEDUPED] Detected repeated page extraction; de-duplicated 32 pages using a conservative fingerprint (head+tail). This typically indicates the PDF text layer is duplicated across pages by the extractor. Dropped pages: [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21]….

## Extraction Stats
- Pages total: 33
- Pages de-duplicated (identical extraction): 32
- Pages with text: 33
- Pages with extraction errors: 0
- Total extracted chars: 3122625

## Chunking Stats
- Chunks: 3
- target_chunk_chars: 30000
- max_chunk_chars: 45000
- overlap_pages: 1
- max_chunks: None
- page_timeout_s: 15

---
## 1) Executive Summary (6–10 bullets)

- A Premier “Market Insights” demo with B. Braun’s marketing-focused group was held virtually on **1/9/2026 at 1:00 PM (Teams)**, explicitly shifting focus away from contract compliance and into market intelligence/insights use cases.
- Premier described Market Insights data as primarily sourced from **hospital ERP transactions** (POs, invoices, inventory levels), with **pharmaceutical wholesaler tracings** used to complete the pharmacy purchasing picture (noting the standard app is **not yet** showing wholesale data).
- Core capabilities discussed: hospital-level segmentation/targeting, cross-sell/leakage analysis, portfolio gap analysis (including “expected to reality”), taxonomy mapping/crosswalks, competitive intelligence, and delivery via **dashboards vs data feeds**.
- Data presentation is designed to preserve **facility blinding** (hospital rows shown, but IDN hierarchy intentionally not displayed); limited geography (e.g., **state / 3-digit ZIP**) may be used without revealing identities.
- Premier asserted broad visibility into purchasing when captured in ERP—i.e., **“everything these hospitals are buying, not just what is on contract”**—and emphasized **SKU-level** granularity tied to Premier’s item master (including drugs).
- Pricing analytics are available with confidentiality guardrails: **no facility-level pricing**; pricing can be rolled up (e.g., manufacturer/class of trade) and/or by geography (e.g., 3-digit ZIP).
- A “triple play” cross-sell framework for B. Braun’s IV ecosystem was discussed; B. Braun noted the commercial framing is more outpatient-focused, but the framework could apply broadly.
- The team requested transparency/validation aids (e.g., **data dictionary/attribute list** and an **Excel sample cut**) and proposed validating CAPS/compounding/nutrition-related representation via a **client-provided SKU list**.
- The pre-built app was positioned as a **lightweight way to start** but is currently **acute ERP-focused** and missing pharmaceutical wholesale data; Premier expects wholesale to be added in **~3–4 months**.
- Next step is an internal B. Braun debrief to select the highest-value use case and decide the preferred engagement model (app vs custom dashboards vs data feeds), followed by a tailored follow-up demo.

---

## 2) Meeting Context

- **Meeting title:** “Confirmed-BBraun MI Demo -virtual”  
- **Date/time:** **1/9/2026 1:00 PM**  
- **Platform:** Microsoft Teams  
- **Attendees/purpose (as stated):** B. Braun regrouped with a **smaller, marketing-focused group** to go deeper on Premier **Market Insights / market intelligence** after a prior session emphasized contract compliance.
- **Framing:** B. Braun currently extracts data into **Power BI**, but showed interest in starting with **Premier dashboards** while requesting access to underlying attributes/samples to validate what drives outputs.

---

## 3) Key Decisions / Confirmations

- **Scope for this call:** Contract compliance was **de-emphasized/skipped** in favor of market insights/market intelligence.
- **Purchasing coverage (ERP-based):** Premier stated they can see **“everything these hospitals are buying, not just what is on contract”** when it flows through the ERP.
- **ERP + wholesale for pharmacy completeness:** Premier described combining ERP data with **pharmaceutical wholesaler tracings** to produce a more comprehensive view; however, the **standard app** shown is currently **acute ERP-focused** and **does not yet include wholesale data**.
- **Blinding approach:** The view is at **individual hospital** level; **IDN hierarchy exists** but is intentionally not displayed to preserve blinding.
- **Tableau enhancements:** Adding filters/sorting (e.g., sort by market share/volume) is feasible and described as a small configuration effort.
- **Pricing constraints:** Premier confirmed **no facility-level pricing** will be provided; only rolled-up and/or geographic rollups (e.g., **3-digit ZIP**) due to confidentiality/contract constraints.
- **Taxonomy mapping:** Premier confirmed they can map B. Braun taxonomy to Premier taxonomy and cross-reference competitor items so competitive products can be analyzed within the client taxonomy.

---

## 4) Open Questions / Follow-ups

- **Data source scope:** Whether Premier accesses **pharmacy management systems** in addition to ERP (response given: **“Not to my knowledge”**).
- **Category definition detail:** What exactly is included in categories like **“infusion sets and accessories”**; Premier said they could pull up/clarify the contents.
- **Workflow capability confirmation:** Whether users can filter to hospitals above a given share threshold in one category (e.g., **≥70% fluids**) and then evaluate gaps in another category (answer in provided summaries: **unknown**).
- **Engagement model decision:** Whether B. Braun wants to start with **dashboards only** vs also pursue a **data stream/data feed** (still undecided).
- **Primary use case selection:** Which category/use case should anchor the next iteration (examples raised: injectables, infusion, safety IV catheters; premix categorization was unclear in the moment).
- **CAPS/compounding/nutrition representation:** Confirmation that key products/competitors (e.g., **Fragran Sterl Service** and **QUVA**, as mentioned) and substitutes are represented—pending SKU validation/sample cut.
- **Taxonomy acceptance:** Whether **Premier taxonomy is acceptable** for the intended analyses (explicitly open).
- **Best-value path:** Which internal use case is the “best use case that has the most value” to pursue first (explicitly open).

---

## 5) Risks / Dependencies

- **Dependency on wholesale data timing:** The standard app is **missing pharmaceutical wholesale data** today; Premier expects to roll it in within **~3–4 months** (timing risk if pharmacy completeness is critical immediately).
- **Validation dependency (SKU list):** Ability to confirm CAPS/compounding/nutrition coverage and produce a representative sample cut depends on B. Braun providing **SKU names/part numbers (and optionally volume)**.
- **Taxonomy dependency:** Portfolio gap and cross-sell analyses depend on agreement that **Premier taxonomy (and/or mapped taxonomy)** is acceptable.
- **Confidentiality guardrails:** Facility-level pricing and certain facility-identifying constructs (e.g., IDN rollups) are constrained; analysis designs must work within these limits.
- **Decision dependency:** Progress depends on B. Braun aligning internally on whether to prioritize **app vs custom dashboards vs data feeds**, and selecting a first use case to demo/scope.

---

## 6) Suggested Next-Step Email (short draft)

Subject: Next steps: Premier Market Insights — use case selection + SKU list for sample cut

Hi Matt/Audrey,  
Thank you for the Market Insights walkthrough on 1/9. Internally we’re going to debrief over the next few days and align on the highest-value initial use case (app vs custom dashboards and whether we also want to explore a data feed).

In parallel, we’ll send a SKU list (name + part number; volume if available) for the CAPS/compounding/nutrition-related items so you can confirm representation and provide an Excel sample cut and the attribute list/data dictionary we discussed.

Once we’ve aligned on the use case, we’d like to schedule a follow-up demo focused on that scenario and any key category-definition questions (e.g., what’s included in “infusion sets and accessories”).

Best,  
[Name]  
B. Braun
